Roche's Q4 sales helped by Covid-19 test business
Swiss drugmaker Roche got a fourth-quarter lift from its Covid-19 test business, where higher sales offset a decline at its drugs unit whose revenue was dragged down by the pandemic and patent-expired cancer drugs that lost ground to rivals.
Business
• 04 Feb 21
